IMPROVING THE TREATMENT OF PHLEGMON OF THE MAXILLOFACIAL REGION

dc.contributor.authorSH.YU.Muxammedova
dc.contributor.authorD.R.Fattayeva
dc.contributor.authorA.A.Kholikov
dc.date.accessioned2025-12-31T13:49:55Z
dc.date.issued2022-11-30
dc.description.abstractOverweight people suffer diseases worse than people without pathology. More than half (54.1%) of patients with FSLD are overweight or obese, with a male to female ratio of 1.8:1. In 6.7% of cases of FCLO, there is a lack of body weight.
dc.formatapplication/pdf
dc.identifier.urihttps://scholarexpress.net/index.php/wbss/article/view/1740
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/46784
dc.language.isoeng
dc.publisherScholar Express Journal
dc.relationhttps://scholarexpress.net/index.php/wbss/article/view/1740/1516
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWorld Bulletin of Social Sciences; Vol. 16 (2022): WBSS; 144-147
dc.source2749-361X
dc.subjectoverweight people
dc.subjectphlegmon
dc.subjectpatients
dc.subjectdiseases
dc.titleIMPROVING THE TREATMENT OF PHLEGMON OF THE MAXILLOFACIAL REGION
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
shyumuxammedova_2022_improving_the_treatment_of_phlegmon_of_t.pdf
item.page.filesection.size
142.58 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections